64 related articles for article (PubMed ID: 9415786)
1. Pap smear outreach: a randomized controlled trial in an HMO.
Binstock MA; Geiger AM; Hackett JR; Yao JF
Am J Prev Med; 1997; 13(6):425-6. PubMed ID: 9415786
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services.
Lynch FL; Whitlock EP; Valanis BG; Smith SK
Prev Med; 2004 Apr; 38(4):403-11. PubMed ID: 15020173
[TBL] [Abstract][Full Text] [Related]
3. Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females.
Thrall JS; McCloskey L; Spivak H; Ettner SL; Tighe JE; Emans SJ
J Adolesc Health; 1998 Mar; 22(3):184-9. PubMed ID: 9502004
[TBL] [Abstract][Full Text] [Related]
4. Papanicolaou testing among Vietnamese Americans: results of a multifaceted intervention.
Nguyen TT; McPhee SJ; Gildengorin G; Nguyen T; Wong C; Lai KQ; Lam H; Mock J; Luong TN; Bui-Tong N; Ha-Iaconis T
Am J Prev Med; 2006 Jul; 31(1):1-9. PubMed ID: 16777536
[TBL] [Abstract][Full Text] [Related]
5. Taiwan's national health insurance system and the application of preventive care: the case of Pap smear testing.
Lin YJ; Chen CS; Liu TC; Lin HC
Public Health; 2008 Sep; 122(9):857-61. PubMed ID: 18617202
[No Abstract] [Full Text] [Related]
6. Comparison of a community outreach service with opportunity screening for cervical cancer using Pap smears.
Chang HC; Hsiung HY; Chen SI; Yen AM; Chen TH
J Public Health (Oxf); 2007 Jun; 29(2):165-72. PubMed ID: 17389674
[TBL] [Abstract][Full Text] [Related]
7. Harvard HMO improves Pap smear screening.
Herman R
QA Rev; 1989 Oct; 1(3):2-3. PubMed ID: 10318359
[No Abstract] [Full Text] [Related]
8. Promotion of cervical screening among nonattendees: a partial cost-effectiveness analysis.
Oscarsson MG; Benzein EG; Wijma BE; Carlsson PG
Eur J Cancer Prev; 2007 Dec; 16(6):559-63. PubMed ID: 18090130
[TBL] [Abstract][Full Text] [Related]
9. Pap screening in a U.S. health plan.
Insinga RP; Glass AG; Rush BB
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical cancer: will women accept less?
Sirovich BE; Woloshin S; Schwartz LM
Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
[TBL] [Abstract][Full Text] [Related]
12. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
Bateson DJ; Weisberg E
Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
[TBL] [Abstract][Full Text] [Related]
13. Clinical inquiries. Should we discontinue Pap smear screening in women aged>65 years?
Curran DR; Stigleman S; Neher JO
J Fam Pract; 2004 Apr; 53(4):308-10. PubMed ID: 15068776
[No Abstract] [Full Text] [Related]
14. Pressing the key pad: trial of a novel approach to health promotion advice.
Corkrey R; Parkinson L; Bates L
Prev Med; 2005 Aug; 41(2):657-66. PubMed ID: 15917066
[TBL] [Abstract][Full Text] [Related]
15. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
16. The Pap smear: a victim of its own success?
Steigman CK; Vernick JP
MLO Med Lab Obs; 2002 Aug; 34(8):8-14; quiz 14-5. PubMed ID: 12228932
[No Abstract] [Full Text] [Related]
17. More Mother's Days.
Zablocki E
Healthplan; 1997; 38(2):19-22. PubMed ID: 10176848
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
19. Increasing women's participation in Pap smear screening in Australia--how can we tell if the national policy is effective?
Shelley J; Street A
Aust Health Rev; 1992; 15(2):190-9. PubMed ID: 10119050
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
